WillettMS, BertchKE, RichDS, EreshefskyL. Prospectus on the economic value of clinical pharmacy services. A position statement of the American College of Clinical Pharmacy. Pharmacotherapy1989; 9:45–56.
2.
JonesLA, GonzalezER, ReinesHD, VenitzJ. Assessment of 24-hour gastric pH measurements in trauma patients receiving intravenous famotidine by intermittent bolus versus continuous infusion administration. Ann Pharmacother1994; 28:841–4.
3.
OlsenKM, HillerC, CrispK, AckermanBH. Effect of histamine receptor antagonists as a single intravenous dose on gastric pH and volume in critically ill patients (abstract). Pharmacotherapy1991; 11:286.
4.
EstesLL, FuhsDW. Hemodynamic effects of bolus injection of famotidine and ranitidine in critically ill patients. ASHP Midyear Clinical Meeting, New Orleans, LA, December 8–12, 1991.
5.
OhT, FrankoTG. Implementing therapeutic interchange of intravenous famotidine for Cimetidine and ranitidine. Am J Hosp Pharm1990; 47:1547–51.
6.
TreemWR, DavisPM, HyamsJS. Suppression of gastric acid secretion by intravenous administration of famotidine in children. J Pediatr1991; 118:812–6.
